
Desmoglein III Antibody (Vesiculobullous disorders)









Desmoglein III is an important protein that helps maintain the integrity of the skin and mucous membranes. The Desmoglein III Antibody (Vesiculobullous disorders) test detects antibodies in the blood that target Desmoglein III. Desmoglein III antibodies in the blood are indicative of autoimmune blistering disorders of the skin or mucous membranes like pemphigus. By identifying the presence of these Desmoglein III antibodies, this test aids doctors in diagnosing and monitoring these conditions, differentiating between various blistering diseases, and determining the most effective treatment course for patients. You may be recommended this test if you are suspected of an autoimmune blistering disorder like pemphigus based on symptoms like fluid-filled blisters, ulcers, or erosions on your skin or mucous membranes, if you have been diagnosed with pemphigus and need to monitor your condition or evaluate the response to treatment, or if your doctor is trying to differentiate between different types of vesiculobullous disorders.












Understanding Desmoglein III Antibody (Vesiculobullous disorders)
Desmoglein III is an adhesion protein that maintains the structural integrity of mucous membranes and deeper skin layers. In autoimmune blistering conditions like pemphigus vulgaris, the immune system mistakenly produces autoantibodies against desmoglein III, breaking down cell-to-cell adhesion and causing fragile blisters and erosions.
The Desmoglein III Antibody (Vesiculobullous disorders) test is primarily used to confirm pemphigus vulgaris, particularly when blisters and erosions affect the mouth, throat, esophagus, or skin. It also helps distinguish pemphigus vulgaris from pemphigus foliaceus, which is associated with desmoglein I antibodies. Doctors may recommend this test if you are suspected of having an autoimmune blistering disorder or if you already have a confirmed diagnosis of pemphigus and require monitoring of disease activity and treatment response. Additionally, it aids in differentiating between subtypes of pemphigus and other vesiculobullous disorders, allowing for accurate diagnosis and effective management.
No special preparation is required for this test. You can eat and drink as per your routine. Inform your doctor about all the medications and supplements that you are currently taking, as these may affect the test results.
Test result ranges are approximate and may differ slightly between labs depending on the methodology and laboratory guidelines.
Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.
What does Desmoglein III Antibody (Vesiculobullous disorders) measure?
The Desmoglein III Antibody (Vesiculobullous disorders) test measures the presence of autoantibodies against desmoglein 3 in the blood. Desmoglein 3 is a protein primarily expressed in the mucous membranes and the deeper layers of the epidermis, where it plays a critical role in holding skin and mucosal cells together. When the immune system produces autoantibodies targeting desmoglein 3, these connections are disrupted, leading to painful blisters and erosions on the mucous membranes and sometimes on the skin. A positive result strongly supports a diagnosis of pemphigus vulgaris. Additionally, the level of antibodies detected can help assess disease activity, monitor progression, and guide treatment decisions.





FAQs related to Desmoglein III Antibody (Vesiculobullous disorders)
- Delavarian Z, Layegh P, Pakfetrat A, Zarghi N, Khorashadizadeh M, Ghazi A. Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity. J Clin Exp Dent. 2020 May 1;12(5):e440-e445. [Accessed 26 Sep. 2025]. Available From:
- Amagai M, Nishikawa T, Nousari HC, Anhalt GJ, Hashimoto T. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest. 1998 Aug 15;102(4):775-82. [Accessed 26 Sep. 2025]. Available From:
- Ingold CJ, Sathe NC, Khan MAB. Pemphigus Vulgaris. [Updated 2024 Mar 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:
- Porro AM, Seque CA, Ferreira MCC, Enokihara MMSES. Pemphigus vulgaris. An Bras Dermatol. 2019 Jul 29;94(3):264-278. [Accessed 26 Sep. 2025]. Available From:
Other tests
- PT INR (Prothrombin Time with INR)
- HIV 1 and 2 Antibody, Rapid Screening Test
- Viral Marker Screening (HIV, HBsAg, Anti-HCV)
- Total IgE
- Rheumatoid Factor - Quantitative
- STD Panel (Sexually Transmitted Diseases Panel)
- STD Panel (Sexually Transmitted Diseases Panel),
- HIV Combo (Antigen And Antibody) Test
- Anti-CCP Antibody
- Lipid Profile, Non Fasting
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)













